This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2018 Mar;67(3):833-836.

doi: 10.1002/hep.29583. Epub 2018 Jan 26.

Cystic fibrosis transmembrane conductance regulator: Actin(g) as a master regulator of cholangiocyte function

Andrew P Feranchak¹

Affiliations

PMID: 29023826
DOI: 10.1002/hep.29583

Editorial

Cystic fibrosis transmembrane conductance regulator: Actin(g) as a master regulator of cholangiocyte function

Andrew P Feranchak. Hepatology. 2018 Mar.

. 2018 Mar;67(3):833-836.

doi: 10.1002/hep.29583. Epub 2018 Jan 26.

Author

Andrew P Feranchak¹

Affiliation

¹ Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX.

PMID: 29023826
DOI: 10.1002/hep.29583

No abstract available

PubMed Disclaimer

Comment on

Src kinase inhibition reduces inflammatory and cytoskeletal changes in ΔF508 human cholangiocytes and improves cystic fibrosis transmembrane conductance regulator correctors efficacy.
Fiorotto R, Amenduni M, Mariotti V, Fabris L, Spirli C, Strazzabosco M. Fiorotto R, et al. Hepatology. 2018 Mar;67(3):972-988. doi: 10.1002/hep.29400. Epub 2018 Jan 26. Hepatology. 2018. PMID: 28836688 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Medical
- Genetic Alliance